BioSmart Co.Ltd Cash Flow Quality Index
BioSmart Co.Ltd cash flow quality index. BioSmart Co.Ltd (038460) has a Cash Flow Quality Index of 1.89x as of September 2025. Operating cash flow of ₩7.59 Billion exceeds net income of ₩4.01 Billion, indicating high earnings quality where cash backs reported profits. See BioSmart Co.Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of BioSmart Co.Ltd (2012–2024)
Cash flow quality index of BioSmart Co.Ltd from 2012 to 2024. Historical Cash Flow Quality Index for BioSmart Co.Ltd across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore cash flow to debt ratio of BioSmart Co.Ltd to assess how comfortably operating cash covers total debt obligations.
BioSmart Co.Ltd Cash Flow Quality Index by Year (2012–2024)
BioSmart Co.Ltd cash flow quality index by year from 2012 to 2024. Year-by-year earnings quality comparison for BioSmart Co.Ltd. For the full cash flow conversion analysis, see 038460 cash flow conversion.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 3.60x | ₩3.80 Billion | ₩1.06 Billion | ▲ +4896.1% |
| 2023 | 0.07x | ₩1.17 Billion | ₩16.18 Billion | ▼ -99.1% |
| 2022 | 7.75x | ₩5.59 Billion | ₩721.31 Million | ▲ +796.9% |
| 2021 | 0.86x | ₩1.20 Billion | ₩1.39 Billion | ▲ +1141.6% |
| 2019 | -0.08x | ₩-1.84 Billion | ₩22.15 Billion | ▼ -107.3% |
| 2018 | 1.13x | ₩5.81 Billion | ₩5.14 Billion | ▲ +410.9% |
| 2017 | -0.36x | ₩-1.76 Billion | ₩4.83 Billion | ▼ -62.2% |
| 2015 | -0.22x | ₩-509.17 Million | ₩2.27 Billion | ▼ -112.8% |
| 2014 | 1.76x | ₩1.31 Billion | ₩743.14 Million | ▲ +80.7% |
| 2013 | 0.97x | ₩3.85 Billion | ₩3.96 Billion | ▼ -67.8% |
| 2012 | 3.02x | ₩8.62 Billion | ₩2.86 Billion | — |